New Jersey Bills Would Reject Some FDA Restrictions on Terminal Patients
TRENTON, N.J. (Feb. 22, 2018) – Two bills introduced in the New Jersey state legislature would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Sen. Joseph Vitale (D-Middlesex) introduced Senate Bill 955 (S955) and Rep. Pamela Lampitt (D-Cherry Hill)…